In its latest study, Viking Therapeutics (VKTX) has found promising early results in a trial for its GLP-1 weight-loss drug. Morgan Stanley upgraded Roblox (RBLX) to Overweight and raised its ...

U.S. inflation data, Fed rate hike expectations, more earnings in focus. Roblox stock is a buy ahead of Q2 results, due Tuesday. Rivian shares set to struggle amid ongoing headwinds. Focus now shifts ...

Roblox (RBLX) is in focus after Hindenburg Research alleged that the gaming platform's metrics are inflated and there are reputational risks for advertisers who use it.

Online gaming and social platform Roblox on Thursday handily beat Wall Street's targets for the first quarter and guided higher for the current period. Roblox stock jumped in early trading.